Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Surgery

Treatment Strategies and Surgical Options

At a Glance

Surgery is the primary treatment for Multiple Symmetric Lipomatosis (MSL), utilizing either radical lipectomy or liposuction to remove fat masses. While there is no cure and recurrence is high, alcohol cessation is critical to stabilize the disease and slow its progression.

Managing Multiple Symmetric Lipomatosis (MSL) can be challenging because there is currently no cure or standardized “one-size-fits-all” treatment plan. Instead, treatment is highly individualized, focusing on relieving physical pressure, improving mobility, and managing appearance [1][2].

Surgical Interventions: The Mainstay of Care

Surgery is the primary way to manage the fat masses, especially when they cause pain or interfere with breathing and swallowing. There are two main approaches:

  • Radical Lipectomy (Surgical Excision): This is a traditional surgery where a surgeon makes an incision to physically remove the fat tissue.
    • Pros: It allows for more complete removal of the fat, which may lead to lower recurrence rates. It also gives the surgeon a clearer view of nearby nerves and blood vessels to avoid injury [3][4].
    • Cons: It is more invasive, leaves larger scars, and requires a longer recovery time [3].
  • Liposuction: This involves sucking the fat out through a small tube (cannula).
    • Pros: It is less invasive with smaller scars and a faster recovery [1].
    • Cons: Because MSL fat is non-encapsulated and often “tougher” than normal fat, it can be very difficult to remove completely with liposuction alone. This may lead to a higher chance of the fat returning sooner [3].
    • Tumescent Liposuction: Many surgeons use a “tumescent solution” (like Klein’s solution)—a mix of saline, lidocaine, and epinephrine—injected into the fat before surgery. This helps firm up the fat, reduces bleeding, and makes it easier to remove [5][4].

The Reality of Recurrence

It is important to have realistic expectations: MSL has a high rate of recurrence. In some studies, about 39% of patients saw the fat return within an average of 3.8 years after surgery [6][7]. Because the underlying metabolic “glitch” is still present, the body may simply begin creating new fat cells in the same areas over time [8].

Lifestyle Management: The Role of Alcohol

While alcohol cessation is not a cure and will not “melt away” existing fat deposits, it is considered a critical part of long-term management [9][10].

  • Slowing Progression: Stopping alcohol can help stabilize the disease and may prevent the masses from growing larger or spreading further [11][12].
  • Improving Symptoms: Some patients report improvements in breathing issues and sleep apnea after they stop drinking [12].

Experimental and Emerging Options

Researchers are looking for ways to treat MSL at the cellular level, though these are not yet “standard of care”:

  • Rapamycin (mTOR Inhibitors): Because MSL involves overactive cell growth pathways, drugs like rapamycin are being studied to see if they can slow down the multiplication of fat cells [13].
  • Deoxycholic Acid: This is an injectable substance used to dissolve small amounts of fat (often under the chin). Some reports show success using it for MSL, but it is typically only useful for very small, localized areas [14].

Because MSL is a chronic, lifelong condition, your treatment journey may involve multiple surgeries and a focus on managing systemic health, such as liver function and metabolic wellness [15][2].

Common questions in this guide

What is the best surgery for Multiple Symmetric Lipomatosis?
Treatment is highly individualized based on your specific symptoms and fat locations. Radical lipectomy allows for more complete fat removal and lower recurrence, while liposuction is less invasive and offers a faster recovery.
Will the fat come back after MSL surgery?
Yes, Multiple Symmetric Lipomatosis has a high rate of recurrence. Because the underlying metabolic issue remains, the body often creates new fat cells in the same areas, with studies showing a return of fat masses in many patients within a few years.
Does stopping alcohol cure Multiple Symmetric Lipomatosis?
Stopping alcohol will not cure MSL or shrink existing fat deposits. However, it is a critical part of long-term management because it can help stabilize the disease, prevent masses from growing larger, and improve breathing issues.
Are there medications or injections to treat MSL fat deposits?
While surgery is the standard of care, experimental treatments are being researched. Drugs like rapamycin and fat-dissolving injections like deoxycholic acid are being studied, though injections are typically only useful for very small, localized areas.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given the location of my fat deposits, would you recommend radical lipectomy or liposuction for the most complete removal?
  2. 2.What is your personal recurrence rate for patients you have treated for MSL?
  3. 3.Is it safe for me to consider experimental treatments like rapamycin or deoxycholic acid injections, or should I stick to standard surgical options?
  4. 4.Do you use tumescent solutions (like Klein's solution) during surgery to minimize bleeding and improve the outcome?
  5. 5.How will we monitor for the recurrence of fat deposits after my procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Madelung Disease Epidemiology and Clinical Characteristics: a Systemic Review.

    Liu Q, Lyu H, Xu B, Lee JH

    Aesthetic plastic surgery 2021; (45(3)):977-986 doi:10.1007/s00266-020-02083-5.

    PMID: 33492475
  2. 2

    Madelung's disease with alcoholic liver disease and acute kidney injury: A case report.

    Wu L, Jiang T, Zhang Y, et al.

    World journal of clinical cases 2021; (9(27)):8199-8206 doi:10.12998/wjcc.v9.i27.8199.

    PMID: 34621881
  3. 3

    Madelung's Disease: Lipectomy or Liposuction?

    Chen CY, Fang QQ, Wang XF, et al.

    BioMed research international 2018; (2018()):3975974 doi:10.1155/2018/3975974.

    PMID: 29682541
  4. 4

    Madelung's disease -a case series from a single-center experience.

    Łącka M, Wojciechowska J, Bernecka P, et al.

    Frontiers in surgery 2025; (12()):1636822 doi:10.3389/fsurg.2025.1636822.

    PMID: 41113128
  5. 5

    Lipectomy for madelung disease using tumescent technique: a cross-sectional study.

    Duc NQ, Tien NP, Tu NT, et al.

    Annals of medicine and surgery (2012) 2023; (85(6)):2550-2558 doi:10.1097/MS9.0000000000000806.

    PMID: 37363562
  6. 6

    Lipomatoses.

    Al Ghazal P, Grönemeyer LL, Schön MP

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(3)):313-327 doi:10.1111/ddg.13460.

    PMID: 29431910
  7. 7

    Madelung's Disease: Revision of 59 Surgical Cases.

    Pinto CI, Carvalho PJ, Correia MM

    Aesthetic plastic surgery 2017; (41(2)):359-368 doi:10.1007/s00266-016-0759-x.

    PMID: 28032179
  8. 8

    Bilateral symmetric lipomatosis of the orbit in Madelung's disease.

    Lumyongsatien M, Selva D

    Orbit (Amsterdam, Netherlands) 2022; (41(2)):268-270 doi:10.1080/01676830.2020.1852261.

    PMID: 33243058
  9. 9

    Madelung disease: A case report.

    Gao H, Xin ZY, Yin X, et al.

    Medicine 2019; (98(3)):e14116 doi:10.1097/MD.0000000000014116.

    PMID: 30653136
  10. 10

    Diagnostic and surgical challenges of progressive neck and upper back painless masses in Madelung's disease: A case report and review of literature.

    Yan YJ, Zhou SQ, Li CQ, Ruan Y

    World journal of clinical cases 2022; (10(1)):361-370 doi:10.12998/wjcc.v10.i1.361.

    PMID: 35071540
  11. 11

    Case Report of a patient with Madelung's disease combined with alcoholic liver disease and liver cirrhosis.

    Gu Z, Hao Y, Duan J, Zhao K

    Frontiers in medicine 2025; (12()):1695921 doi:10.3389/fmed.20251695921.

    PMID: 41347003
  12. 12

    A case of Madelung's disease presenting with obstructive sleep apnea.

    Segsarnviriya C, Chirakalwasan N

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2020; (16(9)):1603-1605 doi:10.5664/jcsm.8622.

    PMID: 32515345
  13. 13

    Adipose tissue-derived stem cells from affected and unaffected areas in patients with multiple symmetric lipomatosis show differential regulation of mTOR pathway genes.

    Felthaus O, Schön T, Schiltz D, et al.

    Clinical hemorheology and microcirculation 2018; (69(1-2)):141-151 doi:10.3233/CH-189107.

    PMID: 29758934
  14. 14

    Madelung Disease Treated With Deoxycholic Acid.

    Rodriguez M, Beal BT, Khetarpal S, Vidimos A

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2021; (47(6)):879-880 doi:10.1097/DSS.0000000000002722.

    PMID: 32897938
  15. 15

    A Chinese patient with Madelung's disease and alcoholic cardiomyopathy: a case report and literature review.

    Zhao H, Ma XL, Yu K, et al.

    European review for medical and pharmacological sciences 2024; (28(13)):3905-3911 doi:10.26355/eurrev_202407_36522.

    PMID: 39012230

This page provides general educational information about MSL treatment options. It does not replace professional medical advice. Always consult your surgeon or healthcare provider to determine the safest and most effective treatment plan for your specific case.

Get notified when new evidence is published on Multiple symmetric lipomatosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.